The program is a collaboration of the UK CURE Alliance and Center for Clinical and Translational Science, who together moved the funding mechanism from concept to first award in 20 days.

Pharmacy graduate students David Henson (in the MD/PhD program) and David Nardo, PharmD (who were both supported by UK Center for Clinical and Translational Science’s NIH-funded TL1 pre-doctoral training program) are working to uncover potential new indicators of heart disease.